- Exchange: Tel Aviv
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Protalix BioTherapeutics Inc
+ Add to WatchlistPLX:IT
1,860.00 ILs 33.00 1.81%As of 10:24:54 ET on 06/19/2013.
Snapshot for Protalix BioTherapeutics Inc (PLX)
| Open: | 1,950.00 | Day's Range: | 1,860.00 - 1,988.00 | Volume: | 821,226 |
|---|---|---|---|---|---|
| Previous Close: | 1,827.00 | 52wk Range: | 1,797.00 - 2,600.00 | 1-Yr Rtn: | -25.72% |
Key Statistics for PLX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. TA-100 | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.1270 |
| Est. PEG Ratio | - |
| Market Cap (M ILS) | 1,739.16 |
| Shares Outstanding (M) | 93.50 |
| 30 Day Average Volume | 63,596 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PLX
Company Profile & Key Executives for PLX
Protalix BioTherapeutics Inc. is a biotechnology company that has developed plant cell culture technology and a bioreactor system.
| David AviezerPresident/CEO | Tzvi PalashChief Operating Officer |
| Yoseph ShaaltielExec VP:Research & Development | Einat Brill AlmonSenior VP:Product Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PLX News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page